MICROPULSE: TRANS-SCLERAL CYCLOPHOTOCOAGULATION
Traditionally, ciliary body destruction has been
used to treat uncontrolled intra-ocular pressure following maximal tolerable
medical therapy. This is due to the large number of complications seen with
this procedure.
However, recently a new technique of sub-threshold laser or
micropulse laser, is able to provide selective destruction of the ciliary body
in a controlled manner. This avoids most of the complications seen with other
modalities. Therefore, this procedure of micropulse-trans-scleral cyclophotocoagulation
(MP-TSCPC) can be used over a wide variety of cases, though the indications for such
procedures are still evolving.
We recently published a study of our experience with MP-TSCPC. Hopefully, the studies on MP-TSCPC will validate each other in expanding the use of this modality in glaucoma management.
No comments:
Post a Comment